Edward A Pesicka
CIK 1439487 · President & CEO · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$55.15M
Companies
4
Total Filings
90
Lifetime Open-Market Net
-$81.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FTRE | Director | 52,453 | $20.71 | $1.09M | $0 | 6 | 2026-06-12 |
| ACH | President & CEO | 1,072,785 | $3.22 | $3.45M | $0 | 2 | 2026-05-19 |
| ACCENDRA HEALTH INC/VA/ (OMI) Delisted | President & CEO | 1,149,422 | $2.80 | $3.22M | -$26.09M | 33 | 2025-05-16 |
| TMO | Senior Vice President | 87,891 | $575.85 | $50.61M | -$55.49M | 43 | 2015-03-09 |
Recent Filings · Page 2 of 9
90 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-16 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Tax (F) | −45,604 | -$902.0K | EDGAR |
| 2024-03-18 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Tax (F) | −58,126 | -$1.45M | EDGAR |
| 2024-03-05 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Grant (A) | +148,134 | $0 | EDGAR |
| 2024-01-18 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Grant (A) | +366 | $5.9K | EDGAR |
| 2023-07-19 | FTRE | Grant (A) | — | $0 | EDGAR |
| 2023-07-05 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Grant (A) | +923 | $15.0K | EDGAR |
| 2023-06-20 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Sell (S) | −77,560 | -$1.49M | EDGAR |
| 2023-06-16 | ACH | Notice (144) | −38,780 | -$749.2K | EDGAR |
| 2023-06-15 | ACH | Notice (144) | −38,780 | -$728.7K | EDGAR |
| 2023-06-12 | ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Sell (S) | −237,856 | -$4.99M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.